Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2026-01-10 @ 8:02 PM
Study NCT ID:
NCT00542451
Status:
COMPLETED
Last Update Posted:
2024-06-26
First Post:
2007-10-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2014-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-09
First Submit QC Date:
None
Study First Post Date:
2007-10-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-11-01
Results First Submit QC Date:
None
Results First Post Date:
2023-03-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-24
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL